CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Down 97.4% in March

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 10,800 shares, a drop of 97.4% from the March 15th total of 414,600 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 108.0 days.

CanSino Biologics Price Performance

CanSino Biologics stock remained flat at C$3.20 during trading hours on Tuesday. The stock’s fifty day moving average is C$4.17 and its 200-day moving average is C$3.87. CanSino Biologics has a 52-week low of C$1.98 and a 52-week high of C$4.90.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.